This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Feedback

We welcome your feedback, which will help improve this site.

Feedback form

Cancer subspecialty areas and Cancer Specialty Group

 

Contents

Cancer subspecialty areas

The NIHR Clinical Research Network (CRN) Cancer Portfolio is divided into 13 subspecialty areas.

  • Brain Cancer
  • Breast Cancer
  • Children and Young People’s (CYP) Cancer
  • Colorectal Cancer
  • Gynaecological Cancer
  • Haematological Oncology
  • Head and Neck Cancer
  • Lung Cancer
  • Sarcoma Cancer
  • Skin Cancer
  • Supportive and Palliative Care, Psychosocial oncology and Survivorship (SPCPS)
  • Upper Gastrointestinal Cancer
  • Urology

The NIHR Clinical Research Network (CRN) is made up of 15 Local Clinical Research Networks that cover the length and breadth of England. To help drive research into the different subspecialty areas each one has a subspecialty lead or subspecialty champion for each subspecialty who promotes and supports research within their subspecialty area in their local NHS Trusts.

At a national level these groups come together to manage the respective national subspecialty portfolio through a programme of subspecialty meetings organised by the CRN Cancer Specialty. The group actively engages with funders of research and other stakeholders to help ensure that there is a continuous pipeline of high quality research studies and the capacity to deliver these successfully in the NHS. They are also called upon as key opinion leaders to provide expert advice on the development and delivery of studies.

If you would like to get in touch with the subspecialty leads please contact crncancer@nihr.ac.uk

Cancer Specialty Group

Each of the 15 Local Clinical Research Networks has a nominated local lead for Cancer research who promotes and supports this research in their local NHS Trusts.

At a national level the group is chaired by Dr Pippa Corrie, NIHR CRN National Specialty Lead for Late Phase and International Trials.

The local leads and Chair come together to manage the NIHR CRN Cancer Portfolio overall. This involves regularly reviewing the progress of studies, identifying barriers to recruitment and coming up with solutions and strategies to help overcome those barriers. The group actively engages with funders of research and other stakeholders to help ensure that there is a continuous pipeline of high quality research studies and the capacity to deliver these successfully in the NHS. They are also called upon as key opinion leaders to provide expert advice on the development and delivery of studies.

If you would like to get in touch with the Cancer Specialty Group please contact crncancer@nihr.ac.uk